Kato Takenori, Hasegawa Toshinori, Kuwabara Kyoko, Ohno Masasuke, Kuramitsu Shunichiro, Naito Takehiro, Mizuno Akihiro, Sakai Yosuke, Oishi Hiroyuki
Department of Neurosurgery, Komaki City Hospital, Komaki, Aichi, Japan.
Department of Pathology, Komaki City Hospital, Komaki, Aichi, Japan.
J Neurosurg Case Lessons. 2025 Feb 17;9(7). doi: 10.3171/CASE24737.
The management of recurrent brain metastases after initial stereotactic radiosurgery (SRS) remains challenging, with high local recurrence rates following salvage surgery. While preoperative SRS has shown promise for newly diagnosed metastases, its application in post-SRS recurrences is largely unexplored.
The authors treated three patients with recurrent brain metastases using preoperative re-irradiation followed by resection. Gamma Knife SRS was performed at marginal doses of 16-18 Gy, followed by resection within 24-48 hours. Local control was achieved in all patients without radiation-related complications. Histopathological examination confirmed the presence of viable tumor cells and radiation-induced changes. Follow-up magnetic resonance imaging revealed no evidence of tumor recurrence or adverse effects. Two patients remained alive at 35 and 19 months, whereas one died of primary cancer progression at 20 months.
Preoperative re-irradiation followed by resection for recurrent brain metastases after initial SRS is feasible and offers promise for short-term safety, local control, and rapid symptom improvement. The ability to promptly implement SRS enables its application in oncological emergencies. These findings suggest that preoperative re-irradiation can be a valuable strategy for managing symptomatic post-SRS recurrent brain metastases that require prompt surgical intervention. https://thejns.org/doi/10.3171/CASE24737.
初次立体定向放射外科治疗(SRS)后复发性脑转移瘤的管理仍然具有挑战性,挽救性手术后局部复发率很高。虽然术前SRS对新诊断的转移瘤已显示出前景,但其在SRS后复发中的应用在很大程度上尚未得到探索。
作者对3例复发性脑转移瘤患者采用术前再照射后切除的方法进行治疗。伽玛刀SRS的边缘剂量为16 - 18 Gy,随后在24 - 48小时内进行切除。所有患者均实现了局部控制,且无放疗相关并发症。组织病理学检查证实存在存活的肿瘤细胞以及放疗引起的改变。随访磁共振成像未发现肿瘤复发或不良反应的证据。2例患者分别在35个月和19个月时仍存活,而1例在20个月时死于原发性癌症进展。
初次SRS后复发性脑转移瘤采用术前再照射后切除的方法是可行的,并且在短期安全性、局部控制和快速症状改善方面具有前景。能够迅速实施SRS使其可应用于肿瘤急症。这些发现表明,术前再照射对于处理需要及时手术干预的SRS后有症状的复发性脑转移瘤可能是一种有价值的策略。https://thejns.org/doi/10.3171/CASE24737